Blood Res.  2013 Dec;48(4):293-295. 10.5045/br.2013.48.4.293.

Successful treatment of steroid resistant hypereosinophilic syndrome with low-dose CsA

• Jung YH
• Han SB
• Park YJ
• Woo IS
• Cho BK
• Han CW

• KMID: 2172879
• DOI: http://doi.org/10.5045/br.2013.48.4.293

Abstract

No abstract available.

MeSH Terms

Hypereosinophilic Syndrome*

Figure

• 

  Fig. 1 Changes in the peripheral blood eosinophil count of case 1 (A) and case 2 (B) over time in relation to the treatment.

Reference

1. Ogbogu PU, Bochner BS, Butterfield JH, et al. Hypereosinophilic syndrome: a multicenter, retrospective analysis of clinical characteristics and response to therapy. J Allergy Clin Immunol. 2009; 124:1319–1325.e3. PMID: 19910029.

2. Cogan E, Schandene L, Crusiaux A, Cochaux P, Velu T, Goldman M. Brief report: clonal proliferation of type 2 helper T cells in a man with the hypereosinophilic syndrome. N Engl J Med. 1994; 330:535–538. PMID: 8302319.

3. Butterfield JH. Interferon treatment for hypereosinophilic syndromes and systemic mastocytosis. Acta Haematol. 2005; 114:26–40. PMID: 15995323.

4. Schandené L, Roufosse F, de Lavareille A, et al. Interferon alpha prevents spontaneous apoptosis of clonal Th2 cells associated with chronic hypereosinophilia. Blood. 2000; 96:4285–4292. PMID: 11110703.

5. Klion AD, Bochner BS, Gleich GJ, et al. Approaches to the treatment of hypereosinophilic syndromes: a workshop summary report. J Allergy Clin Immunol. 2006; 117:1292–1302. PMID: 16750989.

6. Rothenberg ME, Klion AD, Roufosse FE, et al. Treatment of patients with the hypereosinophilic syndrome with mepolizumab. N Engl J Med. 2008; 358:1215–1228. PMID: 18344568.

7. Roufosse F, de Lavareille A, Schandene L, et al. Mepolizumab as a corticosteroid-sparing agent in lymphocytic variant hypereosinophilic syndrome. J Allergy Clin Immunol. 2010; 126:828–835.e3. PMID: 20810155.

8. Nadarajah S, Krafchik B, Roifman C, Horgan-Bell C. Treatment of hypereosinophilic syndrome in a child using cyclosporine: implication for a primary T-cell abnormality. Pediatrics. 1997; 99:630–633. PMID: 9093318.

9. Donald CE, Kahn MJ. Successful treatment of hypereosinophilic syndrome with cyclosporine. Am J Med Sci. 2009; 337:65–66. PMID: 19002011.

10. Roufosse F. Hypereosinophilic syndrome variants: diagnostic and therapeutic considerations. Haematologica. 2009; 94:1188–1193. PMID: 19734412.

11. Klion AD. Recent advances in the diagnosis and treatment of hypereosinophilic syndromes. Hematology Am Soc Hematol Educ Program. 2005; 209–214. PMID: 16304382.